Downregulation of LRRC19 Is Associated with Poor Prognosis in Colorectal Cancer

• Published in: Journal of oncology 2022-06, Vol.2022, p.1-13
• Main Authors: Wang, Ya-Juan, Liu, Man, Jiang, Hui-Ying, Yu, Yong-Wei
• Format: Article
• Language: English
• Subjects: Analysis; Bioinformatics; Biomarkers; Breast cancer; China; Colorectal cancer; Correlation analysis; Datasets; Development and progression; Gene expression; Genes; Genomes; Health aspects; Lung cancer; Medical prognosis; Mortality; Online data bases; Ovarian cancer; Prognosis; Proteins; Retinoids; RNA; Software; Survival analysis; Tumors
• ISSN: 1687-8450; 1687-8450
• DOI: 10.1155/2022/5848823

Objective. Colorectal cancer (CRC) is globally one of the most often diagnosed cancers with high mortality rates. This study aimed to explore novel biomarkers for the diagnosis and prognosis of CRC. Methods. We collected 4 datasets about CRC in GEO and sought differentially expressed genes (DEGs) with GEO2R. Leucine-rich repeat-containing protein 19 (LRRC19) expression was assessed through the Oncomine and TIMER database analyses, which was further confirmed by qRT-PCR of CRC samples. We used online survival analysis tools (GEPIA, PrognoScan, and Kaplan–Meier plotter) to examine the prognostic value of LRRC19 in CRC and other malignancies. GO and KEGG enrichment analyses were employed to explore the biological functions of LRRC19. Finally, we conducted network prediction by STRING and further validation on the GEPIA to discover other molecules that might interact with LRRC19. Results. A total of 21 upregulated and 46 downregulated DEGs were identified from the 4 datasets. The TIMER and Oncomine online analyses showed lower mRNA of LRRC19 in CRC tissues compared with adjacent normal tissues, which was validated by qRT-PCR in CRC patient samples. The survival analysis through the GEPIA and PrognoScan websites revealed that low LRRC19 expression was significantly correlated with poor prognosis in CRC patients. The Kaplan–Meier plotter survival analysis indicated that low LRRC19 expression was significantly associated with the disease progression of patients with ovarian cancer, gastric cancer, breast cancer, and lung cancer. The enrichment analysis suggested that low expression of LRRC19 could be involved in the retinol metabolism and the zymogen granule membrane. Through STRING and GEPIA, it was found that LRRC19 is clearly associated with ZCCHC10, MOB3B, IMMP2L, and TRMT11. Conclusion. LRRC19 mRNA was prominently decreased in human CRC tissues and was significantly associated with shorter survival in CRC patients. LRRC19 might serve as a possible target for early diagnosis and prognosis assessment in CRC.